Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2014

May 6, 2014

284_dirs_2014-05-06_e654f7a3-f086-4c26-acc0-8f5ab1e0a385.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2014-05-04

Reporting Person: FRAZIER KENNETH C (Director, Chairman, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-05-04 Common Stock M 41028.0000 $0.0000 Acquired 351522.0630 Direct
2014-05-04 Common Stock F 18471.0000 $58.2200 Disposed 333051.0630 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-05-04 Restricted Stock Unit $ M 41028.0000 Disposed 2014-05-04 Common Stock (41028.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock - 401(k) Plan 3470.0603 Indirect

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Includes shares acquired and dividends earned through April 7, 2014, in the Merck U.S. Savings Plan, a 401(k) plan.

F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.